… The long duration of this treatment regimen is a major barrier to adherence and has a
significant negative impact on tuberculosis control. 5 World Health Organization [homepage on the …

… , we cannot predict, as of today, their long-term efficacy and the affordability of their use in …
combination regimens. These new regimens are ideally able to treat tuberculosis sustained …

… tuberculosis drugs and drug regimens, there must be a considerable increase in investment
in fundamental research if we are to develop and validate correlates of durable cure. As …

… for the full period of nine months. However, we have used a regimen that employs less
than 100 doses of medication over a nine-month period and has the advantage of being …

… As clinicians and public health experts, we welcome the important opportunity offered by the
short-course regimen to treat eligible patients. The careful and detailed modelling described …

… of treatment of tuberculosis. Where appropriate, evidence levels for the recommended
treatment regimens and … recommended drug regimens for treating of pulmonary tuberculosis, an …

… with MDR-TB on standard short-course chemotherapy after treatment completion.38, 39 Our
… rate of the test regimen was significantly lower than that of the reference regimen (9.6% vs …

… and safety of a short-term regimen (STR) in treating multidrug-resistant tuberculosis (MDR-…
efficacy and shorter duration than the 2011 World Health Organization regimen for MDR-TB …

… functioning tuberculosis programmes. Although several clinical trials supported the use of
daily treatment regimens, studies reporting tuberculosis recurrence after intermittent regimens …

… with minimal side effects on long‐term administration (Schluger 2013). … anti‐tuberculosis
treatment regimen, can enhance the sterilizing and bactericidal effects of combination therapy …